Trial Profile
A CLINICAL TRIAL COMPARING ORAL URACIL/FTORAFUR (UFT) [tegafur] PLUS LEUCOVORIN (LV) [folinic acid] WITH 5-FLUOROURACIL (5-FU) PLUS LV IN THE TREATMENT OF PATIENTS WITH STAGES II AND III CARCINOMA OF THE COLON.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary) ; Fluorouracil; Folinic acid; Folinic acid
- Indications Adenocarcinoma; Colorectal cancer
- Focus Registrational; Therapeutic Use
- 19 Jan 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 11 Apr 2007 Status change
- 01 Feb 2007 QOL results published